REG - Integrated Diag Hdgs - Result of AGM

Integrated Diagnostics HoldingsAnnouncement

Yesterday 17:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260519:nRSS9752Ea&default-theme=true

RNS Number : 9752E  Integrated Diagnostics Holdings PLC  19 May 2026

19 May 2026

INTEGRATED DIAGNOSTICS HOLDINGS PLC (the "Company")

Result of Annual General Meeting ("AGM") held on 19 May 2026

The Company announces that at the Annual General Meeting ("AGM") held today
all resolutions contained in the notice of the meeting, including two special
resolutions were duly passed achieving the requisite majority. Each of the
resolutions put to the AGM was voted on by way of a poll. Resolutions 1 to 14
(inclusive) were passed as ordinary resolutions and resolutions 15 to 16
(inclusive) were passed as special resolutions. The results of the poll for
each resolution were as follows:

 Resolutions                                                                     Votes For    %       Votes Against  %       % of ISC* vote  Votes Withheld
 1. To receive and consider the Company's Audited Financial Statements,          449,179,265  92.70%  35,383,947     7.30%   99.99%          16,014
 together with the Reports of the Directors and the Auditor for the year ended
 31 December 2025.
 2. To re-elect Lord Anthony Tudor St John as a Director. **                     388,943,465  81.39%  88,924,650     18.61%  98.62%          6,711,111
 3. To re-elect Dr. Hend El-Sherbini as a Director.                              442,483,845  92.60%  35,384,149     7.40%   98.62%          6,711,232
 4. To re-elect Sherif El Zeiny as a Director.                                   415,586,438  86.97%  62,281,556     13.03%  98.62%          6,711,232
 5. To re-elect Richard Henry Phillips as a Director. **                         408,459,947  85.48%  69,408,047     14.52%  98.62%          6,711,232
 6. To re-elect Dan Johan Wilmar Olsson as a Director. **                        385,411,374  80.65%  92,456,620     19.35%  98.62%          6,711,232
 7. To re-elect Hussein Hassan Choucri as a Director. **                         385,411,432  80.65%  92,456,562     19.35%  98.62%          6,711,232
 8. To re-elect Yvonne Stillhart as a Director. **                               442,483,262  92.60%  35,384,732     7.40%   98.62%          6,711,232
 9. To re-appoint PwC LLP as Auditor to hold office from the conclusion of this  449,179,696  92.70%  35,383,947     7.30%   99.99%          15,583
 meeting until the conclusion of the next annual general meeting at which
 accounts are laid before the Company.
 10. To authorise the Audit Committee to determine the Auditor's remuneration.   449,179,216  92.70%  35,384,007     7.30%   99.99%          16,003
 11. To declare a final dividend of USD 0.0085 per Share in respect of the year  449,179,762  92.70%  35,384,035     7.30%   99.99%          15,429
 ended 31 December 2025.
 12. Authority to issue and allot shares.                                        427,783,320  88.28%  56,779,959     11.72%  99.99%          15,947
 13. To hold shares as Treasury Shares.                                          449,179,014  92.70%  35,384,276     7.30%   99.99%          15,936
 14. To execute ancillary documents.                                             449,178,807  92.70%  35,384,257     7.30%   99.99%          16,162
 15. To authorise the Directors to dis-apply statutory pre-emption rights. ***   420,653,639  86.81%  63,909,552     13.19%  99.99%          16,035
 16. Authority for the Company to make market purchases of its own shares. ***   449,179,208  92.70%  35,383,950     7.30%   99.99%          16,068

*Issued share capital with voting rights

**Independent Director

***Special resolution

Notes:

1.         All resolutions were passed by the required majority.

2.         Proxy appointments that gave discretion to the Chairman of
the AGM have been included in the "For" total for the appropriate resolution.

3.         Votes "For" and "Against" any resolution are expressed as a
percentage of votes validly cast for that resolution.

4.         A "Vote withheld" is not a vote in law and is not counted
in the calculation of the percentage of shares voted "For" or "Against" any
resolution.

5.         As at the date of the AGM, the Company had 581,326,272
ordinary shares in issue. The Company held no shares in treasury and therefore
the number of total voting rights as at the date of the AGM was 581,326,272.
In accordance with the Company's Articles of Association, on a poll every
member who is present in person or by proxy has one vote for every share held.

6.         The full text of the resolutions passed at the AGM can be
found in the Notice of AGM which is available on the Company's website at
https://investors.idhcorp.com/ (https://investors.idhcorp.com/)

7.         A copy of the special resolutions passed at the AGM will
shortly be submitted to the National Storage Mechanism and will be available
for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

8.         The scrutineer of the poll was MUFG Corporate Markets, the
Company's Share Registrar.

MUFG Corporate Governance Limited

Secretary

LEI: 2138007JN9NUWKKTS790

For further information please contact:

 Integrated Diagnostics Holdings plc
 Tarek Yehia                          tarek.yehia@idhcorp.com (mailto:tarek.yehia@idhcorp.com)
 Investor Relations Director

 Company Secretary                    IDHLondon@cm.mpms.mufg.com (mailto:IDHLondon@cm.mpms.mufg.com)
 MUFG Corporate Governance Limited

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSFMFMUEMSESI



            Copyright 2019 Regulatory News Service, all rights reserved